# Gritstone Bio, Inc.

Canonical: https://abierto.us/vendors/gritstone-bio-inc-wpnlfzk8ma87

- UEI: WPNLFZK8MA87
- CAGE: 9L4G1
- Location: Emeryville, CA
- Awards in window: 1 (3 transactions), $0 obligated, March 11, 2024 to March 12, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50123C00062 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Developing a Next-Generation Vaccine That Drives (A) More Durable and Broad Anti-Spike Neutralizing Antibodies (Nabs) Against Variants of Concern (Vocs), Including Those Not Included in the Vaccine, and (B) T Cells Reactive Against Conserved Targets. https://www.usaspending.gov/award/CONT_AWD_75A50123C00062_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/gritstone-bio-inc-wpnlfzk8ma87.